Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

ILMN

Illumina Inc

Apr 16 • 04:00PM ET

117.69

Dollar change -3.47
Percentage change -2.86	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VO QQQ VUG IVV VOT IBB RSP VHT

Scroll to Statements

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-7.34	Insider Own	0.50%	Shs Outstand	159.00M	Perf Week	-11.89%
Market Cap	18.70B	Forward P/E	47.97	EPS next Y	2.45	Insider Trans	0.89%	Shs Float	158.11M	Perf Month	-7.86%
Income	-1161.00M	PEG	-	EPS next Q	0.04	Inst Own	90.74%	Short Float	3.34%	Perf Quarter	-12.91%
Sales	4.50B	P/S	4.15	EPS this Y	2.31%	Inst Trans	2.72%	Short Ratio	3.12	Perf Half Y	-8.85%
Book/sh	36.13	P/B	3.26	EPS next Y	178.86%	ROA	-10.38%	Short Interest	5.28M	Perf Year	-48.38%
Cash/sh	6.63	P/C	17.74	EPS next 5Y	22.90%	ROE	-18.81%	52W Range	89.00 - 232.23	Perf YTD	-15.48%
Dividend Est.	-	P/FCF	66.32	EPS past 5Y	-	ROI	-14.66%	52W High	-49.32%	Beta	1.21
Dividend TTM	-	Quick Ratio	1.29	Sales past 5Y	7.40%	Gross Margin	60.97%	52W Low	32.24%	ATR (14)	5.34
Dividend Ex-Date	-	Current Ratio	1.66	EPS Y/Y TTM	73.83%	Oper. Margin	-1.62%	RSI (14)	31.59	Volatility	4.45% 3.85%
Employees	12010	Debt/Eq	0.39	Sales Y/Y TTM	-1.72%	Profit Margin	-25.78%	Recom	2.46	Target Price	153.82
Option/Short	Yes / Yes	LT Debt/Eq	0.38	EPS Q/Q	-24.92%	Payout	-	Rel Volume	1.00	Prev Close	121.16
Sales Surprise	3.19%	EPS Surprise	652.69%	Sales Q/Q	3.60%	Earnings	May 02 AMC	Avg Volume	1.69M	Price	117.69
SMA20	-10.55%	SMA50	-13.12%	SMA200	-16.87%	Trades		Volume	1,696,993	Change	-2.86%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185
Dec-15-23	Upgrade	Bernstein	Underperform → Mkt Perform
Dec-14-23	Initiated	Stephens	Overweight	$170
Dec-14-23	Initiated	Guggenheim	Buy	$155
Dec-13-23	Initiated	Wolfe Research	Outperform	$175
Dec-12-23	Downgrade	BofA Securities	Neutral → Underperform	$140 → $100
Dec-11-23	Upgrade	Citigroup	Sell → Neutral	$85 → $120
Nov-10-23	Downgrade	Canaccord Genuity	Buy → Hold	$210 → $120
Sep-28-23	Initiated	Bernstein	Underperform	$111
Jul-05-23	Resumed	JP Morgan	Neutral	$235
Jan-25-23	Downgrade	Argus	Buy → Hold
Jan-05-23	Initiated	Scotiabank	Sector Perform	$216
Dec-12-22	Downgrade	Citigroup	Neutral → Sell	$200 → $180
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$282
Oct-04-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$220 → $270
Sep-28-22	Upgrade	Evercore ISI	In-line → Outperform	$170 → $250
Aug-25-22	Initiated	Credit Suisse	Neutral	$230
Jul-13-22	Downgrade	Barclays	Equal Weight → Underweight	$350 → $150

Show Previous Ratings

Apr-15-24 05:40AM	European Commission approves Illuminas proposed Grail split (MedTech Dive)
Apr-12-24 09:00AM	Illumina's planned divestment of GRAIL approved by the European Commission (PR Newswire)
06:21AM	UPDATE 2-EU approves Illumina's plan to divest cancer test maker Grail (Reuters)
05:49AM	EU approves Illumina's plan to divest cancer test maker Grail (Reuters)
Apr-10-24 08:16AM	Search for Cancer Blood Test Continues Despite Illumina-Grail Deals Failure (Barrons.com)
11:37PM	Loading…
Apr-09-24 11:37PM	Illumina CFO steps down amid executive shakeup (MedTech Dive)
05:28PM	UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed (Reuters)
04:32PM	Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed (Reuters)
04:28PM	CORRECTED-UPDATE 1-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed (Reuters)
04:18PM	CORRECTED-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra named successor (Reuters)
04:05PM	Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer (PR Newswire)
Apr-05-24 02:27PM	Nasdaqs Nosebleed Section: 3 Expensive Stocks to Sell Before Its Too Late (InvestorPlace)
12:45PM	Why More Clinical Labs Are Turning to Whole-Genome Sequencing for Cancer (ACCESSWIRE)
Apr-04-24 05:00PM	Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024 (PR Newswire)
Apr-02-24 09:45AM	Giving Students a New Window on Genomic Technologies (ACCESSWIRE)
07:43PM	Loading…
Mar-30-24 07:43PM	20 Foods To Reduce Cancer Risk (Insider Monkey)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-25-24 06:17AM	Court adviser sides with Illumina in EU row that triggered Grail fine (MedTech Dive)
Mar-21-24 06:37PM	Why Illumina Stock Zoomed Higher on Thursday (Motley Fool)
05:44AM	UPDATE 2-EU merger powers may be curbed after court adviser backs Illumina fight (Reuters)
05:12AM	EU merger powers may be curbed after court adviser backs Illumina fight (Reuters)
05:01AM	EU court should back Illumina's appeal against EU review of Grail deal, court adviser says (Reuters)
Mar-18-24 12:40PM	A Biobank for the Americas and a Genomics Lab Power Precision Health for All (ACCESSWIRE)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-14-24 07:42PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Mar-13-24 06:43AM	10 Biggest Stocks Targeted By Activist Investors Right Now (Insider Monkey)
Mar-12-24 04:50PM	S&P 500 Gains and Losses Today: Oracle Surges as Results Show AI Advancement (Investopedia)
02:41PM	Carl Icahn Drops Plans for New Proxy Fight at Illumina (Bloomberg)
01:57PM	Exclusive-Icahn drops Illumina board challenge threat, sources say (Reuters)
Mar-08-24 08:45AM	Finding the Needle in the Genomic Haystack With DRAGEN (ACCESSWIRE)
03:00PM	Loading…
Mar-07-24 03:00PM	3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise (InvestorPlace)
08:45AM	Video: Give Someone a Fish, You Feed Them - Unlock the Fish Genome, You Feed the World (ACCESSWIRE)
Mar-02-24 02:30PM	FTC's suit against Kroger-Albertsons merger will have a 'chilling effect' on M&A activity (Yahoo Finance)
Feb-28-24 05:52AM	Reasons for the Decline of Illumina (ILMN) (Insider Monkey)
Feb-27-24 03:40AM	Do You Believe in the Growth Prospects of Illumina (ILMN)? (Insider Monkey)
03:09AM	Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China (PR Newswire)
Feb-26-24 06:29PM	Why Illumina Stock Mashed the Market on Monday (Motley Fool)
11:00AM	Illumina Inc CEO Jacob Thaysen Acquires 7,330 Shares (GuruFocus.com)
Feb-24-24 06:50AM	15 Best Shareholder Activism Law Firms (Insider Monkey)
Feb-23-24 07:59AM	Activist Investor Alert: The Top 3 Stocks Carl Icahn Is Targeting in 2024 (InvestorPlace)
Feb-21-24 07:42PM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:00AM	Icahn Enterprises L.P. Announces Management & Financial Update (PR Newswire)
Feb-20-24 10:25AM	Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe (Zacks)
Feb-14-24 07:00PM	Illumina, already facing pressure from Icahn, saw other activists at year end (Reuters) +5.23%
09:40AM	Illumina Named One of Americas Most JUST Companies and Included in the 2024 S&P Global Sustainability Yearbook (ACCESSWIRE)
Feb-09-24 11:19AM	Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:52AM	Q4 2023 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
07:39AM	Illumina (ILMN) Q4 Earnings Surpass Estimates, Margin Down (Zacks)
05:45AM	Illumina cut 12% of global staff over past year: CEO (MedTech Dive)
01:32AM	Analyst Report: Illumina, Inc. (Morningstar Research)
Feb-08-24 06:30PM	Illumina (ILMN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:24PM	Illumina forecasts flat 2024 sales as sluggish demand drags on (Reuters)
04:34PM	Illumina Inc (ILMN) Reports Mixed Fiscal Year 2023 Results Amidst GRAIL Divestiture (GuruFocus.com)
04:24PM	Illumina: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023 (PR Newswire)
09:14AM	Illumina to lay off 111 people at San Diego headquarters (MedTech Dive)
Feb-05-24 09:16AM	Seeking Clues to Illumina (ILMN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Feb-01-24 09:10PM	Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements (InvestorPlace)
Jan-30-24 07:31AM	Illumina (ILMN) Leads the Market With 80% Share (Insider Monkey)
Jan-29-24 07:49PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Jan-28-24 09:25AM	3 Stocks to Buy for the Age of Personalized Medicine (InvestorPlace)
Jan-23-24 08:45PM	Cramer's Lightning Round: Fluor, Illumina and Ferrari (CNBC TV)
Jan-19-24 08:25AM	Heres Why Polen Focus Growth Sold Illumina (ILMN) (Insider Monkey)
Jan-18-24 07:52AM	Here's How the New AI Algorithm Helps Illumina (ILMN) (Insider Monkey)
05:04AM	The Top 3 Stocks in the High-Potential Cancer Testing Market (InvestorPlace)
Jan-17-24 12:04PM	7 Mighty Healthcare Stocks Changing the Game of Medicine (InvestorPlace)
Jan-16-24 10:11AM	Illumina (ILMN) Shares Down 1.2% Post Preliminary Q4 Results (Zacks)
Jan-15-24 07:00AM	Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world (PR Newswire)
Jan-12-24 09:45AM	What 5000 Ancient Human Genomes Can Reveal About European Health and Heritage (ACCESSWIRE)
Jan-11-24 09:45AM	What Happens When a Virus Becomes a Permanent Part of Your Genome? (ACCESSWIRE)
Jan-09-24 05:28PM	Match Group, Juniper- HPE talks, Illumina: Trending Tickers (Yahoo Finance Video)
02:02PM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:00AM	Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023 (PR Newswire)
07:05AM	Why Illumina Rallied 36.6% in December (Motley Fool)
05:38AM	Illumina unveils preliminary fourth-quarter revenue that tops estimates (Investing.com)
03:34AM	Susan Tousi leaves Illumina to become CEO of liquid biopsy firm Delfi (MedTech Dive)
Jan-08-24 12:45PM	Illumina (ILMN) Extends Partnership to Advance Cancer Test (Zacks)
Jan-05-24 09:15AM	Illumina expands collaboration with Janssen to advance molecular residual disease cancer test (PR Newswire)
Jan-04-24 08:17PM	Illumina's story is too messy and uncertain right now, says Jim Cramer (CNBC TV)
04:05PM	Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024 (PR Newswire)
09:15AM	The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk (PR Newswire)
Dec-28-23 01:02PM	Here's Why You Should Retain Illumina (ILMN) Stock for Now (Zacks)
Dec-27-23 10:45AM	ILLUMINA SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Dec-22-23 03:00PM	Final Deadline Approaching for Illumina, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc. (ILMN) Investors of January 9, 2024 Lead Plaintiff Deadline (GlobeNewswire)
Dec-21-23 09:35AM	Nucleus Genomics Wants To Make Personalized Health Care a Reality (ACCESSWIRE)
Dec-19-23 05:28PM	Heard on the Street: Illumina Nears the End of Its Painful Grail Saga (The Wall Street Journal) +8.08%
04:42PM	S&P 500 Gains and Losses Today: Enphase's Cost Cutting Charges Up Solar Stocks (Investopedia)
04:05PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
01:26PM	FTC, DOJ finalize merger guidelines that could impede healthcare M&A (Healthcare Dive)
11:11AM	Hedge Fund and Insider Trading News: Jim Chanos, Carl Icahn, Tiger Global Management, Odey Asset Management, Cevian Capital, Heritage Insurance Holdings Inc (HRTG), and More (Insider Monkey)
11:02AM	Carl Icahn to initiate proxy battle with Illumina again (Yahoo Finance Video)
09:45AM	A Lesser-Known Application of Genomics: Reducing Cow Burp Intensity (ACCESSWIRE)
05:30AM	The 2023 stock market rally isn't just about seven stocks anymore (Yahoo Finance)
05:30AM	The 2023 stock market rally isn't just about 7 stocks anymore (Yahoo Finance)
05:18AM	Grail CEO predicts transformative 2024 amid Illumina split (MedTech Dive)
12:00AM	Could the trustbusters be making a comeback? (Financial Times)
Dec-18-23 04:17PM	These Stocks Are Moving the Most Today: U.S. Steel, Apple, Adobe, SunPower, VF Corp, NIO, and More (Barrons.com)
04:07PM	Illumina Ends Its Controversial Grail Battle With A Divestiture; Shares Rise (Investor's Business Daily)
03:37PM	US Steel & Nippon, Adobe, Illumina: Top M&A announcements (Yahoo Finance Video)
01:55PM	Illumina-Grail $8B Saga Ends After It Battles Regulators For 3 Years (Benzinga)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thaysen Jacob	Chief Executive Officer	Feb 22 '24	Buy	135.29	7,330	991,672	14,861	Feb 26 08:57 AM
Hoyt Aimee L	SVP, Chief People Officer	Nov 07 '23	Sale	112.84	315	35,545	8,314	Nov 09 04:22 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Aug 22 '23	Sale	167.04	500	83,520	45,524	Aug 24 04:19 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jul 24 '23	Sale	190.08	500	95,040	46,022	Jul 26 06:14 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jun 22 '23	Sale	200.00	500	100,000	46,522	Jun 26 05:23 PM
EPSTEIN ROBERT S	Director	May 25 '23	Option Exercise	71.09	7,600	540,284	14,764	May 25 04:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ILMN

Illumina Inc

Upgrade your FINVIZ experience